Literature DB >> 35928854

Novel MRGX2 Antagonists for Treating Diseases.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2022        PMID： 35928854      PMCID： PMC9345377          DOI： 10.1021/acsmedchemlett.2c00262

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  4 in total

Review 1.  Non-IgE-mediated anaphylaxis.

Authors:  Antonella Cianferoni
Journal:  J Allergy Clin Immunol       Date:  2021-04       Impact factor: 10.793

Review 2.  Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies.

Authors:  Helen Kühn; Pavel Kolkhir; Magda Babina; Miriam Düll; Stefan Frischbutter; Jie Shen Fok; Qingqing Jiao; Martin Metz; Jörg Scheffel; Katharina Wolf; Andreas E Kremer; Marcus Maurer
Journal:  J Allergy Clin Immunol       Date:  2020-10-15       Impact factor: 10.793

Review 3.  Atypical opioid receptors: unconventional biology and therapeutic opportunities.

Authors:  Christie B Palmer; Max Meyrath; Meritxell Canals; Evi Kostenis; Andy Chevigné; Martyna Szpakowska
Journal:  Pharmacol Ther       Date:  2021-10-05       Impact factor: 12.310

Review 4.  Current and emerging treatments for chronic spontaneous urticaria.

Authors:  Kirti J Johal; Sarbjit S Saini
Journal:  Ann Allergy Asthma Immunol       Date:  2019-09-05       Impact factor: 6.347
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.